5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Buy
66
BDUUF Quote, Financials, Valuation and Earnings
Last price:
$0.66
Seasonality move
:
3.49%
Day range:
$0.66 - $0.66
52-week range:
$0.64 - $0.80
Dividend yield:
3.37%
P/E ratio:
22.90x
P/S ratio:
3.42x
P/B ratio:
3.58x
Volume:
--
Avg. volume:
750
1-year change:
-14.52%
Market cap:
$10.5B
Revenue:
$3.1B
EPS (TTM):
$0.03
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BDUUF
Bangkok Dusit Medical Services PCL
|
-- | -- | -- | -- | -- |
|
BUGDF
Bumrungrad Hospital PCL
|
-- | -- | -- | -- | -- |
|
CNC
Centene
|
$43.2B | $2.52 | 11.34% | -2.98% | $77.63 |
|
LLY
Eli Lilly and
|
$12.7B | $3.46 | 26.74% | 68.13% | $981.63 |
|
MOH
Molina Healthcare
|
$10.8B | $5.96 | 10.82% | 19.82% | $358.75 |
|
NIVF
NewGenIvf Group
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BDUUF
Bangkok Dusit Medical Services PCL
|
$0.66 | -- | $10.5B | 22.90x | $0.01 | 3.37% | 3.42x |
|
BUGDF
Bumrungrad Hospital PCL
|
$7.91 | -- | $6.3B | 31.81x | $0.09 | 1.86% | 9.44x |
|
CNC
Centene
|
$62.92 | $77.63 | $31.3B | 9.38x | $0.00 | 0% | 0.19x |
|
LLY
Eli Lilly and
|
$776.72 | $981.63 | $697.3B | 63.20x | $1.50 | 0.7% | 14.32x |
|
MOH
Molina Healthcare
|
$327.02 | $358.75 | $17.7B | 15.79x | $0.00 | 0% | 0.44x |
|
NIVF
NewGenIvf Group
|
$3.77 | -- | $2.8M | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BDUUF
Bangkok Dusit Medical Services PCL
|
9.5% | 0.305 | 2.47% | 0.94x |
|
BUGDF
Bumrungrad Hospital PCL
|
0.08% | 0.050 | 0.01% | 4.73x |
|
CNC
Centene
|
39.62% | -0.071 | 60.45% | 1.07x |
|
LLY
Eli Lilly and
|
70.96% | 0.813 | 5.19% | 0.57x |
|
MOH
Molina Healthcare
|
45.33% | -0.817 | 20.09% | 1.57x |
|
NIVF
NewGenIvf Group
|
-- | -0.738 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BDUUF
Bangkok Dusit Medical Services PCL
|
$304.7M | $156.2M | 14.33% | 15.75% | 19.66% | $11.1M |
|
BUGDF
Bumrungrad Hospital PCL
|
$91.3M | $61.4M | 27.69% | 27.72% | 34.95% | $50.9M |
|
CNC
Centene
|
$5.2B | $1.5B | 7.62% | 12.65% | 4.11% | $1.4B |
|
LLY
Eli Lilly and
|
$10.5B | $5.4B | 24.21% | 78.25% | 29.07% | -$1.6B |
|
MOH
Molina Healthcare
|
$1.3B | $433M | 16.29% | 25.66% | 3.89% | $168M |
|
NIVF
NewGenIvf Group
|
-- | -- | -- | -- | -- | -- |
Bangkok Dusit Medical Services PCL vs. Competitors
-
Which has Higher Returns BDUUF or BUGDF?
Bumrungrad Hospital PCL has a net margin of 15.81% compared to Bangkok Dusit Medical Services PCL's net margin of 28.23%. Bangkok Dusit Medical Services PCL's return on equity of 15.75% beat Bumrungrad Hospital PCL's return on equity of 27.72%.
Company Gross Margin Earnings Per Share Invested Capital BDUUFBangkok Dusit Medical Services PCL37.83% $0.01 $3.3B BUGDFBumrungrad Hospital PCL50.5% $0.06 $869.7M -
What do Analysts Say About BDUUF or BUGDF?
Bangkok Dusit Medical Services PCL has a consensus price target of --, signalling downside risk potential of --. On the other hand Bumrungrad Hospital PCL has an analysts' consensus of -- which suggests that it could fall by --. Given that Bangkok Dusit Medical Services PCL has higher upside potential than Bumrungrad Hospital PCL, analysts believe Bangkok Dusit Medical Services PCL is more attractive than Bumrungrad Hospital PCL.
Company Buy Ratings Hold Ratings Sell Ratings BDUUFBangkok Dusit Medical Services PCL0 0 0 BUGDFBumrungrad Hospital PCL0 0 0 -
Is BDUUF or BUGDF More Risky?
Bangkok Dusit Medical Services PCL has a beta of 0.320, which suggesting that the stock is 67.998% less volatile than S&P 500. In comparison Bumrungrad Hospital PCL has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BDUUF or BUGDF?
Bangkok Dusit Medical Services PCL has a quarterly dividend of $0.01 per share corresponding to a yield of 3.37%. Bumrungrad Hospital PCL offers a yield of 1.86% to investors and pays a quarterly dividend of $0.09 per share. Bangkok Dusit Medical Services PCL pays 69.55% of its earnings as a dividend. Bumrungrad Hospital PCL pays out 52.75% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BDUUF or BUGDF?
Bangkok Dusit Medical Services PCL quarterly revenues are $805.5M, which are larger than Bumrungrad Hospital PCL quarterly revenues of $180.8M. Bangkok Dusit Medical Services PCL's net income of $127.4M is higher than Bumrungrad Hospital PCL's net income of $51M. Notably, Bangkok Dusit Medical Services PCL's price-to-earnings ratio is 22.90x while Bumrungrad Hospital PCL's PE ratio is 31.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Bangkok Dusit Medical Services PCL is 3.42x versus 9.44x for Bumrungrad Hospital PCL. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BDUUFBangkok Dusit Medical Services PCL3.42x 22.90x $805.5M $127.4M BUGDFBumrungrad Hospital PCL9.44x 31.81x $180.8M $51M
-
Which has Higher Returns BDUUF or CNC?
Centene has a net margin of 15.81% compared to Bangkok Dusit Medical Services PCL's net margin of 2.81%. Bangkok Dusit Medical Services PCL's return on equity of 15.75% beat Centene's return on equity of 12.65%.
Company Gross Margin Earnings Per Share Invested Capital BDUUFBangkok Dusit Medical Services PCL37.83% $0.01 $3.3B CNCCentene11.16% $2.63 $46.3B -
What do Analysts Say About BDUUF or CNC?
Bangkok Dusit Medical Services PCL has a consensus price target of --, signalling downside risk potential of --. On the other hand Centene has an analysts' consensus of $77.63 which suggests that it could grow by 23.38%. Given that Centene has higher upside potential than Bangkok Dusit Medical Services PCL, analysts believe Centene is more attractive than Bangkok Dusit Medical Services PCL.
Company Buy Ratings Hold Ratings Sell Ratings BDUUFBangkok Dusit Medical Services PCL0 0 0 CNCCentene7 8 0 -
Is BDUUF or CNC More Risky?
Bangkok Dusit Medical Services PCL has a beta of 0.320, which suggesting that the stock is 67.998% less volatile than S&P 500. In comparison Centene has a beta of 0.478, suggesting its less volatile than the S&P 500 by 52.18%.
-
Which is a Better Dividend Stock BDUUF or CNC?
Bangkok Dusit Medical Services PCL has a quarterly dividend of $0.01 per share corresponding to a yield of 3.37%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Bangkok Dusit Medical Services PCL pays 69.55% of its earnings as a dividend. Centene pays out -- of its earnings as a dividend. Bangkok Dusit Medical Services PCL's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BDUUF or CNC?
Bangkok Dusit Medical Services PCL quarterly revenues are $805.5M, which are smaller than Centene quarterly revenues of $46.6B. Bangkok Dusit Medical Services PCL's net income of $127.4M is lower than Centene's net income of $1.3B. Notably, Bangkok Dusit Medical Services PCL's price-to-earnings ratio is 22.90x while Centene's PE ratio is 9.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Bangkok Dusit Medical Services PCL is 3.42x versus 0.19x for Centene. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BDUUFBangkok Dusit Medical Services PCL3.42x 22.90x $805.5M $127.4M CNCCentene0.19x 9.38x $46.6B $1.3B
-
Which has Higher Returns BDUUF or LLY?
Eli Lilly and has a net margin of 15.81% compared to Bangkok Dusit Medical Services PCL's net margin of 21.68%. Bangkok Dusit Medical Services PCL's return on equity of 15.75% beat Eli Lilly and's return on equity of 78.25%.
Company Gross Margin Earnings Per Share Invested Capital BDUUFBangkok Dusit Medical Services PCL37.83% $0.01 $3.3B LLYEli Lilly and82.53% $3.06 $54.4B -
What do Analysts Say About BDUUF or LLY?
Bangkok Dusit Medical Services PCL has a consensus price target of --, signalling downside risk potential of --. On the other hand Eli Lilly and has an analysts' consensus of $981.63 which suggests that it could grow by 26.38%. Given that Eli Lilly and has higher upside potential than Bangkok Dusit Medical Services PCL, analysts believe Eli Lilly and is more attractive than Bangkok Dusit Medical Services PCL.
Company Buy Ratings Hold Ratings Sell Ratings BDUUFBangkok Dusit Medical Services PCL0 0 0 LLYEli Lilly and15 3 1 -
Is BDUUF or LLY More Risky?
Bangkok Dusit Medical Services PCL has a beta of 0.320, which suggesting that the stock is 67.998% less volatile than S&P 500. In comparison Eli Lilly and has a beta of 0.479, suggesting its less volatile than the S&P 500 by 52.104%.
-
Which is a Better Dividend Stock BDUUF or LLY?
Bangkok Dusit Medical Services PCL has a quarterly dividend of $0.01 per share corresponding to a yield of 3.37%. Eli Lilly and offers a yield of 0.7% to investors and pays a quarterly dividend of $1.50 per share. Bangkok Dusit Medical Services PCL pays 69.55% of its earnings as a dividend. Eli Lilly and pays out 44.2% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BDUUF or LLY?
Bangkok Dusit Medical Services PCL quarterly revenues are $805.5M, which are smaller than Eli Lilly and quarterly revenues of $12.7B. Bangkok Dusit Medical Services PCL's net income of $127.4M is lower than Eli Lilly and's net income of $2.8B. Notably, Bangkok Dusit Medical Services PCL's price-to-earnings ratio is 22.90x while Eli Lilly and's PE ratio is 63.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Bangkok Dusit Medical Services PCL is 3.42x versus 14.32x for Eli Lilly and. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BDUUFBangkok Dusit Medical Services PCL3.42x 22.90x $805.5M $127.4M LLYEli Lilly and14.32x 63.20x $12.7B $2.8B
-
Which has Higher Returns BDUUF or MOH?
Molina Healthcare has a net margin of 15.81% compared to Bangkok Dusit Medical Services PCL's net margin of 2.67%. Bangkok Dusit Medical Services PCL's return on equity of 15.75% beat Molina Healthcare's return on equity of 25.66%.
Company Gross Margin Earnings Per Share Invested Capital BDUUFBangkok Dusit Medical Services PCL37.83% $0.01 $3.3B MOHMolina Healthcare11.48% $5.45 $7.9B -
What do Analysts Say About BDUUF or MOH?
Bangkok Dusit Medical Services PCL has a consensus price target of --, signalling downside risk potential of --. On the other hand Molina Healthcare has an analysts' consensus of $358.75 which suggests that it could grow by 9.7%. Given that Molina Healthcare has higher upside potential than Bangkok Dusit Medical Services PCL, analysts believe Molina Healthcare is more attractive than Bangkok Dusit Medical Services PCL.
Company Buy Ratings Hold Ratings Sell Ratings BDUUFBangkok Dusit Medical Services PCL0 0 0 MOHMolina Healthcare6 8 0 -
Is BDUUF or MOH More Risky?
Bangkok Dusit Medical Services PCL has a beta of 0.320, which suggesting that the stock is 67.998% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.633, suggesting its less volatile than the S&P 500 by 36.702%.
-
Which is a Better Dividend Stock BDUUF or MOH?
Bangkok Dusit Medical Services PCL has a quarterly dividend of $0.01 per share corresponding to a yield of 3.37%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Bangkok Dusit Medical Services PCL pays 69.55% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. Bangkok Dusit Medical Services PCL's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BDUUF or MOH?
Bangkok Dusit Medical Services PCL quarterly revenues are $805.5M, which are smaller than Molina Healthcare quarterly revenues of $11.1B. Bangkok Dusit Medical Services PCL's net income of $127.4M is lower than Molina Healthcare's net income of $298M. Notably, Bangkok Dusit Medical Services PCL's price-to-earnings ratio is 22.90x while Molina Healthcare's PE ratio is 15.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Bangkok Dusit Medical Services PCL is 3.42x versus 0.44x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BDUUFBangkok Dusit Medical Services PCL3.42x 22.90x $805.5M $127.4M MOHMolina Healthcare0.44x 15.79x $11.1B $298M
-
Which has Higher Returns BDUUF or NIVF?
NewGenIvf Group has a net margin of 15.81% compared to Bangkok Dusit Medical Services PCL's net margin of --. Bangkok Dusit Medical Services PCL's return on equity of 15.75% beat NewGenIvf Group's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BDUUFBangkok Dusit Medical Services PCL37.83% $0.01 $3.3B NIVFNewGenIvf Group-- -- -- -
What do Analysts Say About BDUUF or NIVF?
Bangkok Dusit Medical Services PCL has a consensus price target of --, signalling downside risk potential of --. On the other hand NewGenIvf Group has an analysts' consensus of -- which suggests that it could fall by --. Given that Bangkok Dusit Medical Services PCL has higher upside potential than NewGenIvf Group, analysts believe Bangkok Dusit Medical Services PCL is more attractive than NewGenIvf Group.
Company Buy Ratings Hold Ratings Sell Ratings BDUUFBangkok Dusit Medical Services PCL0 0 0 NIVFNewGenIvf Group0 0 0 -
Is BDUUF or NIVF More Risky?
Bangkok Dusit Medical Services PCL has a beta of 0.320, which suggesting that the stock is 67.998% less volatile than S&P 500. In comparison NewGenIvf Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BDUUF or NIVF?
Bangkok Dusit Medical Services PCL has a quarterly dividend of $0.01 per share corresponding to a yield of 3.37%. NewGenIvf Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Bangkok Dusit Medical Services PCL pays 69.55% of its earnings as a dividend. NewGenIvf Group pays out -- of its earnings as a dividend. Bangkok Dusit Medical Services PCL's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BDUUF or NIVF?
Bangkok Dusit Medical Services PCL quarterly revenues are $805.5M, which are larger than NewGenIvf Group quarterly revenues of --. Bangkok Dusit Medical Services PCL's net income of $127.4M is higher than NewGenIvf Group's net income of --. Notably, Bangkok Dusit Medical Services PCL's price-to-earnings ratio is 22.90x while NewGenIvf Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Bangkok Dusit Medical Services PCL is 3.42x versus -- for NewGenIvf Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BDUUFBangkok Dusit Medical Services PCL3.42x 22.90x $805.5M $127.4M NIVFNewGenIvf Group-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is BYD a Threat To Tesla Shareholders?
BYD (OTC:BYDDY) has rocketed to the top of China’s booming…
CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 8
Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.
Buy
92
TPB alert for May 8
Turning Point Brands [TPB] is down 6.67% over the past day.
Buy
74
LIVN alert for May 8
LivaNova PLC [LIVN] is up 1.33% over the past day.
